“Steady improvement in renal allograft survival among North American children: a five year appraisal by the North American Pediatric Renal Transplant Cooperative Study.”, Kidney Int, vol. 48, no. 2, pp. 551-3, 1995.
, Renal Transplantation - The NAPRTCS Experience. Los Angeles: UCLA Tissue Typing Laboratory, 1998, p. 13.
“The impact of donor source, recipient age, preoperative immunotherapy and induction therapy on early and late acute rejections in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Pediatr Transplantation, vol. 2, pp. 318-24, 1998.
, “Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, Pediatr Transplantation, vol. 3, pp. 293-300, 1999.
, “The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late acute rejections in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).”, Pediatr Transplant, vol. 2, no. 4, pp. 318-24, 1998.
, , , , “Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study.”, Transplantation, vol. 61, no. 7, pp. 1054-8, 1996.
, , “Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).”, Pediatr Transplant, vol. 3, no. 4, pp. 293-300, 1999.
, “Steady improvements in short-term graft survival of pediatric renal transplants: The North American Pediatric Transplant Cooperative Study (NAPRTCS) experience”, Clinical Transplants, 1999.
, “Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience.”, Clin Transpl, pp. 95-110, 1999.
, , “Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.”, Am J Transplant, vol. 14, no. 5, pp. 1129-35, 2014.
, “Outcomes of Liver Transplant Recipients with Hepatitis C and Human Immunodeficiency Virus Coinfection”, Liver Transpl, vol. 18, pp. 716-726, 2012.
, “Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients”, Am J Transplant, vol. 14, pp. 1129-1135, 2014.
, “Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.”, Liver Transpl, vol. 18, no. 6, pp. 716-26, 2012.
, “Myeloablative Transplantation Using Either Cord Blood or Bone Marrow Leads to Immune Recovery, High Long-Term Donor Chimerism and Excellent Survival in Chronic Granulomatous Disease”, Biol Blood Marrow Transplant, vol. 18, pp. 1368-1377, 2012.
, “Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.”, Biol Blood Marrow Transplant, vol. 18, no. 9, pp. 1368-77, 2012.
, “Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.”, PLoS One, vol. 5, no. 2, p. e9041, 2010.
, “A field trial to assess a blood-stage malaria vaccine.”, N Engl J Med, vol. 365, no. 11, pp. 1004-13, 2011.
, “Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial”, PLoS One, vol. 5, p. e9041, 2010.
, “A Field Trial to Assess a Blood-Stage Malaria Vaccine”, N Engl J Med, vol. 365, pp. 1004-1013, 2011.
, “Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration.”, Invest Ophthalmol Vis Sci, vol. 49, no. 6, pp. 2696-708, 2008.
,